19-58477743-G-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_017908.4(ZNF446):c.449G>T(p.Gly150Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000198 in 1,613,036 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_017908.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF446 | NM_017908.4 | c.449G>T | p.Gly150Val | missense_variant | 3/7 | ENST00000594369.6 | NP_060378.1 | |
ZNF446 | NM_001304453.1 | c.449G>T | p.Gly150Val | missense_variant | 2/6 | NP_001291382.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF446 | ENST00000594369.6 | c.449G>T | p.Gly150Val | missense_variant | 3/7 | 1 | NM_017908.4 | ENSP00000472802 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000328 AC: 5AN: 152218Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000401 AC: 1AN: 249634Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 134986
GnomAD4 exome AF: 0.0000185 AC: 27AN: 1460818Hom.: 0 Cov.: 31 AF XY: 0.0000151 AC XY: 11AN XY: 726738
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152218Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74356
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 11, 2022 | The c.449G>T (p.G150V) alteration is located in exon 3 (coding exon 2) of the ZNF446 gene. This alteration results from a G to T substitution at nucleotide position 449, causing the glycine (G) at amino acid position 150 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at